Procyrion Inc
04/10/2015 | Press release | Archived content
Circulatory Support Without Surgery
Procyrion, Inc. of Houston, TX is developing the first catheter-deployed circulatory assist device designed for long-term treatment of early-stage heart failure. Thinner than a #2 pencil, Aortix has the potential to become a low-risk treatment option for a broad range of patients.
Procyrion Inc published this content on April 10, 2015, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 21, 2026 at 05:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]